Dr. Ngangyola Thikhar
- Last Updated On :
Dr. NGANGYOLA TUIKHAR
Dr. Ngangyola Tuikhar is a Scientist-I in the Department of Onco-Haematopathology, Dr. BRA-IRCH, AIIMS, New Delhi, where she has been working since October 2023. She completed her Ph.D. in Biotechnology in 2020 from the Institute of Bioresources and Sustainable Development (IBSD), Imphal.
Dr. Ngangyola Tuikhar has extensive research experience in microbiology, molecular biology, microbial genomics, metagenomics, flow cytometry, and bioinformatics, with hands-on experience in Next Generation Sequencing, Whole Genome Sequencing, Nanopore sequencing, and microbial genomic data analysis.
Dr. Ngangyola Tuikhar has contributed as a Quality Manager to the successful achievement of NABL accreditation for the department, supporting quality management, documentation, and compliance with laboratory accreditation requirements.
Area of Interests
Dr. Ngangyola Tuikhar research interests focus on developing targeted therapeutic strategies for Acute Myeloid Leukemia (AML) using CRISPR-based gene editing approaches to identify and validate novel molecular targets. Dr. Ngangyola Tuikhar is also interested in investigating TKI resistance in Chronic Myeloid Leukemia (CML), including resistance markers beyond known BCR::ABL1 kinase domain mutations. Future research will focus on integrating CRISPR-based functional studies, single-cell transcriptomics, and genomic approaches to identify leukemic stem cell-specific molecular drivers, mechanism and pathways associated with TKI resistance, with the aim of developing novel targeted therapeutic strategies for haematological malignancies.
Selected publications
Google Scholar
https://scholar.google.com/citations?hl=en&authuser=2&user=I5-yZugAAAAJ
